Libifem Wins Innovation Award

July 24, 2013
Libifem
Nutraceutical Business & Technology (NBT) selected Gencor’s Libifem as a Finalist in the Most Innovative Ingredient category. The award was presented at VitaFoods Europe on May 14-16, 2013 in Geneva, Switzerland.
 
Libifem is a standardized fenugreek extract clinically proven to promote a woman’s healthy libido, sexual vitality and desire. Fenugreek extracts have a long history of safe use. Libifem is easy to use in product formulations. It is available for delivery in powders, soft gels and tablets.
> Find out more about Libifem
 

Probiotics Protected by Intelicaps

Dr. Paul Clayton

Gencor is entering the probiotics market, offering products manufactured using a new, patented technology developed by Vesale Pharma.

 
Called Intelicaps, this technology microencapsulates probiotics to remain stable under extreme conditions, making possible a wider variety of formulations, including simple tablets, chewable tablets, ready-made capsules, sachets, and sticks, as well combinations with vitamin C, zinc, and citrate. In addition, Intelicaps’ resistance to heat and humidity allows for distribution to countries with high temperatures. Gencor is the exclusive U.S. agent for Vesale Pharma.
> Read More
 

Study: Caralluma Fimbriata Whittles the Waist

Slimaluma

As recently published in the journal  Complementary Therapies in Medicine, Australian researchers assessed the effects of Caralluma fimbriata on 33 overweight and obese Australians. At the end of 12 weeks, those who received the Caralluma fimbriata supplement had lost an average of 2.6 inches from their waists, compared to only 1 inch from the placebo group.

 
Caralluma fimbriata is available through the ingredient Slimaluma. Gencor has conducted two human clinical trials and six safety studies to ensure the safety and efficacy of Slimaluma. In 2006, Slimaluma was affirmed GRAS (Generally Recognized as Safe). It is certified Kosher, Halal and Organic, and meets DSHEA requirements under section 413(a)(1).
> Read More
 

Play for a Great Cause at
SSW Charity Poker Tourney

Slimaluma
Gencor is the Royal Flush Sponsor of the Neptune Annual Charity Poker Tournament, featuring guest of honor John Elway. Proceeds benefit Vitamin Angels, a non-profit organization dedicated to reducing child mortality by connecting children in need with micronutrients.
 
Location:         Las Vegas, The Venetian
Date:                SupplySide West, Nov. 13, 2013
Fee:                  $1,100 per player (U.S.)
Reservations:  a.remy@neptunebiotech.com or (450) 687-2262.
 

Sidestepping Sarcopenia:
Avoiding the Loss of Muscle Mass

By Dr Paul Clayton, Chief Scientific Advisor, Gencor

SlimalumaDr. Paul Clayton
From early middle age on, most of us lose muscle mass. It’s not inevitable – a very physically active lifestyle can delay or prevent this – but people who are physically inactive lose up to 5% of their muscle mass per decade from age 30.
 
This age-related loss of muscle mass, known as sarcopenia, affects over 20% of 60-70 year-olds and half of those over age 75.  As numbers of elderly folk increase, the socio-economic costs of ill health caused by sarcopenia have become very significant. The most recent (2004) survey of US costs put them as high as $26 billion per year (Janssen et al ’04). In 2008 the Centers for Disease Control named sarcopenia as one of the top five biggest health risks facing the US population. The EU has adopted a similar position.
> Read More